US2011076281A1PendingUtilityA1
Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders
Est. expiryJul 21, 2026(expired)· nominal 20-yr term from priority
A61P 9/10A61P 7/02A61P 43/00A61P 1/18A61P 19/08A61P 19/00A61P 13/12G01N 2800/10A61K 9/0024A61M 5/31596G01N 33/6887C07K 2317/76A61K 38/1875C12N 9/6491A61K 45/06A61K 2039/505A61K 38/4886C07K 16/22G01N 2333/96486G01N 33/573A61K 39/3955
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Uses of BMP-1 isoforms for diagnosing and treating defects and disorders of bone and soft tissues are described. Also described is a newly isolated variant of the BMP-1 isoform BMP-1-3.
Claims
exact text as granted — not AI-modified1 . A method for diagnosing acute pancreatitis in an individual comprising: testing a blood sample from an individual to determine the presence in the sample of the BMP-1 isoform BMP-1-7, wherein the presence of said BMP-1 isoform in circulating blood of said individual is indicative of acute pancreatitis in the individual.
2 . A method for diagnosing chronic renal failure in an individual comprising: testing a blood sample from an individual to determine the presence in the sample of BMP-1 isoforms BMP-1-3 and BMP-1-5, wherein the presence of both said BMP-1 isoforms in circulating blood of said individual is indicative of chronic renal failure in said individual.
3 . A method of treating ischemic acute renal failure in an individual comprising administering a BMP-1 isoform systemically to the individual after diagnosis of renal injury.
4 . A method of treating ischemia/reperfusion damage to a kidney in an individual comprising: administering to the individual one or more antibody molecules specific for one or more BMP-1 isoforms in an amount effective to inhibit ischemia/reperfusion injury in said individual.
5 . The method according to claim 4 , wherein the one or more antibody molecules to one or more BMP-1 isoforms is administered systemically to the individual prior to an ischemia/reperfusion event.
6 . The method according to claim 4 , wherein an antibody molecule to BMP-1-1, an antibody molecule to BMP-1-3, or a combination of such antibody molecules is administered to the individual.Join the waitlist — get patent alerts
Track US2011076281A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.